[Alzheimer disease and other dementia in France: Identification, management and neuroleptic use (2007-2009)].

@article{Tuppin2012AlzheimerDA,
  title={[Alzheimer disease and other dementia in France: Identification, management and neuroleptic use (2007-2009)].},
  author={Philippe Tuppin and Anne Cuerq and Alain Weill and Philippe Ricordeau and Hubert Allemand},
  journal={Revue neurologique},
  year={2012},
  volume={168 2},
  pages={152-60}
}
Numbers of patients with Alzheimer's disease or other dementia (ADD) are necessary for care organisation and indicators development as rates of neuroleptics prescription will have a negative risk-benefit balance. Among people of 60 years old and more covered by the general regime (11 millions, 80% of French people), patients with ADD were identified by at least one of the following criteria: long-term affection status for ADD (67.1% of the identified), refunds for Alzheimer medication (67.5… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

High prevalence of dementia in women with osteoporosis.

Joint, bone, spine : revue du rhumatisme • 2017
View 5 Excerpts
Highly Influenced

Alzheimer’s Disease—A Panorama Glimpse

International journal of molecular sciences • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…